Reconsidering sex-based stereotypes of COPD

Primary Care Respiratory Journal

Volumn 20, Issue 4, 2011, Pages 370-378

  Ohar, Jill ^a   Fromer, Leonard ^b   Donohue, James F ^c  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

COPD; Female; Gender; Male; Phenotypes; Sex; Stereotypes

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; FORMOTEROL; SALMETEROL;

AGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE PREDISPOSITION; GENDER BIAS; HUMAN; OXYGEN THERAPY; PROGNOSIS; PULMONARY REHABILITATION; REVIEW; SEX DIFFERENCE; SMOKING CESSATION; SYMPTOM; SYSTEMATIC REVIEW;

EID: 82455206122     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2011.00070     Document Type: Review

References (110)

1. Mannino DM, Homa DM, Akinbami LF, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002;51(6):1-16.
2. Ohar JA, Sadeghnejad A, Donohue J, Meyers DA, Bleecker ER. Do symptoms predict COPD in smokers? Chest 2010;137(6):1345-53. http://dx.doi.org/10.1378/chest.09-2681
3. Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006;367(9518):1216-19. http://dx.doi.org/10.1016/S0140-6736(06)68516-4
4. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPDrelated hospitalizations in the United States, 1979 to 2001. Chest 2005;128(4):2005-11. http://dx.doi.org/10.1378/chest.128.4.2005
5. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airway obstruction and the risk for lung cancer. Ann Intern Med 1987;106(4):512-18.
6. Nomura A, Stemmermann GN, Chyou P-H, Marcus EB, Buist AS. Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis 1991;144(2):307-11.
7. Islam SS, Schottenfeld D. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Cancer Epidemiol Biomarkers Prev 1994;3(4):289-95.
8. Mapel DW, Dedrick D, Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. COPD 2005;2(1):35-41. http://dx.doi.org/10.1081/COPD-200050671
9. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007;176(3):285-90. http://dx.doi.org/10.1164/rccm.200612-1792OC
10. Lazarus R, Sparrow D, Weiss ST. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 1998;12(3):641-5. http://dx.doi.org/10.1183/09031936.98.12030641
11. Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 2003;114(1):10-14. http://dx.doi.org/10.1016/S0002-9343(02)01297-4
12. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 2007;101(1):177-85. http://dx.doi.org/10.1016/j.rmed.2006.03.029
13. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comoribidites in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5(4):549-55. http://dx.doi.org/10.1513/pats.200709-148ET
14. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008;5(2):133-8. http://dx.doi.org/10.1080/15412550801941349
15. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Updated 2007. Available at: www.goldcopd.org (accessed 7 May 2008).
16. Silverman EK, Weiss ST, Drazen JM, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162(6):2152-8.
17. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General-Executive Summary. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006.
18. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004;10(2):98-103. http://dx.doi.org/10.1097/00063198-200403000-00003
19. Schwela D. Cooking smoke: a silent killer. People Planet 1997;6(3):24-5.
20. Pérez-Padilla R, Regalado J, Vedal S, et al. Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am J Respir Crit Care Med 1996;154(3 Pt 1):701-6.
21. Liu S, Zhou Y, Wang X, et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 2007;62(10):889-97. http://dx.doi.org/10.1136/thx.2006.061457
22. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001;164(3):372-7.
23. Birring SS, Brightling CE, Bradding P, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med 2002;166(8):1078-83. http://dx.doi.org/10.1164/rccm.200203-245OC
24. Patel BD, Luben RN, Welch AA, et al. Childhood smoking is an independent risk factor for obstructive airways disease in women. Thorax 2004;59(8):682-6. http://dx.doi.org/10.1136/thx.2003.010215
25. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003;21(6):1017-23. http://dx.doi.org/10.1183/09031936.03.00053202
26. Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ. The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res 2005;7(4):581-90. http://dx.doi.org/10.1080/14622200500185199
27. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89(21):1580-6. http://dx.doi.org/10.1093/jnci/89.21.1580
28. Becklake MR, Kauffman F. Gender differences in airway behaviour over the human life span. Thorax 1999;54(12):1119-38. http://dx.doi.org/10.1136/thx.54.12.1119
29. Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996;335(13):931-7. http://dx.doi.org/10.1056/NEJM199609263351304
30. Koster A, Bosma H, van Lenthe FJ, Kempen GI, Mackenbach JP, van Eijk JT. The role of psychosocial factors in explaining socio-economic differences in mobility decline in a chronically ill population: results from the GLOBE study. Soc Sci Med 2005;61(1):123-32. http://dx.doi.org/10.1016/j.socscimed.2004.11.045
31. Carlson CL, Cushman M, Enright PL, Cauley JA, Newman AB. Hormone replacement therapy is associated with higher FEV1 in elderly women. Am J Respir Crit Care Med 2001;163(2):423-8.
32. Dransfield MT, Davis JJ, Gerald LB, Bailey WC. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med 2006;100(6):1110-16. http://dx.doi.org/10.1016/j.rmed.2005.09.019
33. Massaro D, Massaro GD. Toward therapeutic pulmonary alveolar regeneration in humans. Proc Am Thorac Soc 2006;3(8):709-12. http://dx.doi.org/10.1513/pats.200605-127SF
34. Gan WQ, Cohen SB, Man SF, Sin DD. Sex-related differences in serum cotinine concentrations in daily cigarette smokers. Nicotine Tob Res 2008;10(8):1293-300. http://dx.doi.org/10.1080/14622200802239132
35. Leynaert B, Bousquet J, Henry C, Liard R, Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med 1997;156(5):1413-20.
36. Kanner RE, Connett JE, Altose MD, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 1994;150(4):956-61.
37. Paoletti P, Carrozzi L, Viegi G, et al. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. Am J Respir Crit Care Med 1995;151(6):1770-7.
38. Connett JE, Murray RP, Buist AS, et al. Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol 2003;157(11):973-9. http://dx.doi.org/10.1093/aje/kwg083
39. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153(6 Pt 1):1802-11.
40. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyperresponsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000;356(9238):1313-17. http://dx.doi.org/10.1016/S0140-6736(00)02815-4
41. Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis 1991;143(6):1224-30.
42. Xu X, Weiss ST, Rijcken B, Schouten JP. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. Eur Respir J 1994;7(6):1056-61.
43. Xu X, Li B, Wang L. ender difference in smoking effects on adult pulmonary function. Eur Respir J 1994;7(3):477-83. http://dx.doi.org/10.1183/09031936.94.07030477
44. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender differences in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997;10(4):822-7.
45. Watson L, Vonk JM, Lofdahl CG, et al. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the EUROSCOP study. Respir Med 2006;100(4):746-53. http://dx.doi.org/10.1016/j.rmed.2005.08.004
46. Gan WQ, Man SF, Postma DS, Camp P, Sin D. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 2006;7:52. http://dx.doi.org/10.1186/1465-9921-7-52
47. De Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest 2005;128(4):2012-6. http://dx.doi.org/10.1378/chest.128.4.2012
48. Pata O, Atis S, Utku Oz A, et al. The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. Maturitas 2003;46(3):213-18. http://dx.doi.org/10.1016/S0378-5122(03)00191-9
49. Mueller JE, Frye C, Brasche S, Heinrich J. Association of hormone replacement therapy with bronchial hyper-responsiveness. Respir Med 2003;97(8):990-2. http://dx.doi.org/10.1016/S0954-6111(03)00128-8
50. Cevrioglu AS, Fidan F, Unlu M, et al. The effects of hormone therapy on pulmonary function tests in postmenopausal women. Maturitas 2004;49(3):221-7. http://dx.doi.org/10.1016/j.maturitas.2004.01.009
51. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000;53(7):755-61. http://dx.doi.org/10.1016/S0895-4356(99)00211-5
52. De Torres JP, Campo A, Casanova C, Aguirre-Jaime A, Zulueta J. Gender and chronic obstructive pulmonary disease in high-risk smokers. Respiration 2006;73(3):306-10. http://dx.doi.org/10.1159/000090051
53. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61(11):935-9. http://dx.doi.org/10.1136/thx.2006.062802
54. Schirnhofer L, Lamprecht B, Vollmer WM, et al. COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) study. Chest 2007;131(1):29-36. http://dx.doi.org/10.1378/chest.06-0365
55. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28(3):523-32. http://dx.doi.org/10.1183/09031936.06.00124605
56. Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006;100(10):1767-74. http://dx.doi.org/10.1016/j.rmed.2006.01.026
57. Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J 2006;28(2):319-22. http://dx.doi.org/10.1183/09031936.06.00138105
58. Watson L, Vestbo J, Postma DS, et al. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004;98(12):1207-13. http://dx.doi.org/10.1016/j.rmed.2004.05.004
59. Martinez FJ, Curtis JL, Sciurba F, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007;176(3):243-52. http://dx.doi.org/10.1164/rccm.200606-828OC
60. Watson L, Schouten JP, Lofdahl CG, Pride NB, Laitinen LA, Postma DS; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. Predictors of COPD symptoms: does the sex of the patient matter? Eur Respir J 2006;28(2):311-18. http://dx.doi.org/10.1183/09031936.06.00055805
61. Rodriguez-Gonzalez Moro M, Izquierdo JL, Anton E, de Lucas P, Martin A; MUVICE Study Group. Health-related quality of life in outpatient women with COPD in daily practice: the MUVICE Spanish study. Respir Med 2009;103(9):1303-12. http://dx.doi.org/10.1016/j.rmed.2009.04.002
62. Fan VS, Ramsey SD, Giardino ND, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007;167(21):2345-53. http://dx.doi.org/10.1001/archinte.167.21.2345
63. Katsura H, Yamada K, Wakabayashi R, Kida K. Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 2007;12(3):427-32. http://dx.doi.org/10.1111/j.1440-1843.2007.01075.x
64. Van Ede L. Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999;54(8):688-92. http://dx.doi.org/10.1136/thx.54.8.688
65. Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 2003;12(1):3-21. http://dx.doi.org/10.1002/mpr.138
66. Chavannes NH, Huibers MJ, Schermer TR, et al. Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients. Fam Pract 2005;22(6):604-07. http://dx.doi.org/10.1093/fampra/cmi056
67. Laurin C, Lavoie KL, Bacon SL, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007;132(1):148-55. http://dx.doi.org/10.1378/chest.07-0134
68. Ninot G, Fortes M, Poulain M, et al. Gender difference in coping strategies among patients enrolled in an inpatient rehabilitation program. Heart Lung 2006;35(2):130-6. http://dx.doi.org/10.1016/j.hrtlng.2005.09.004
69. Kennedy TC, Proudfoot SP, Franklin WA, et al. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res 1996;56(20):4673-8.
70. Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol 1993;138(5):281-93.
71. Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 1993;54(1):44-8. http://dx.doi.org/10.1002/ijc.2910540108
72. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88(3-4):183-92. http://dx.doi.org/10.1093/jnci/88.3-4.183
73. Henschke CI, Yip R, Miettinen OS. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 2006;296(2):180-4. http://dx.doi.org/10.1001/jama.296.2.180
74. Ahmed LA, Schirmer H, Bjornerem A, et al. The gender-and age-specific 10-year and lifetime absolute fracture risk in Tromso, Norway. Eur J Epidemiol 2009;24(8):441-8. http://dx.doi.org/10.1007/s10654-009-9353-8
75. Camp PG, Coxson HO, Levy RD, et al. Sex differences in emphysema and airway disease in smokers. Chest 2009;136(6):1480-8. http://dx.doi.org/10.1378/chest.09-0676
76. Sverzellati N, Calabro E, Randi G, et al. Sex differences in emphysema phenotype in smokers without airflow obstruction. Eur Respir J 2009;33(6):1320-8. http://dx.doi.org/10.1183/09031936.00109808
77. Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J 2009;34(4):858-65. http://dx.doi.org/10.1183/09031936.00167908
78. Laitinen T, Hodgson U, Kupiainen H, et al. Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease. COPD 2009;6(4):256-62. http://dx.doi.org/10.1080/15412550903051799
79. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119(6):1691-5. http://dx.doi.org/10.1378/chest.119.6.1691
80. Miravitlles M, de la Roza C, Naberan K, et al. Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care. [Spanish] Arch Bronconeumol 2006;42(1):3-8. http://dx.doi.org/10.1016/S1579-2129(06)60106-7
81. Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest 2007;132(2):403-09. http://dx.doi.org/10.1378/chest.06-2846
82. Cydulka RK, Rowe BH, Clark S, Emerman CL, Rimm AR, Camargo CA Jr. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbations. Acad Emerg Med 2005;12(12):1173-9. http://dx.doi.org/10.1111/j.1553-2712.2005.tb01493.x
83. Bjornson W, Rand C, Connett JE, et al. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health 1995;85(2):223-30. http://dx.doi.org/10.2105/AJPH.85.2.223
84. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine Tob Res 2003;5(1):111-16. http://dx.doi.org/10.1080/1462220021000060482
85. Schmitz JM. Smoking cessation in women with cardiac risk. Am J Med Sci 2003;326(4):192-6. http://dx.doi.org/10.1097/00000441-200310000-00008
86. Ussher MH, Taylor AH, West R, McEwen R. Does exercise aid smoking cessation? A systematic review. Addiction 2000;95(2):199-208. http://dx.doi.org/10.1046/j.1360-0443.2000.9521996.x
87. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupriopion, a nicotine patch, or both smoking cessation. N Engl J Med 1999;340(9):685-91. http://dx.doi.org/10.1056/NEJM199903043400903
88. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296(1):56-63. http://dx.doi.org/10.1001/jama.296.1.56
89. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296(1):47-55. http://dx.doi.org/10.1001/jama.296.1.47
90. Perkins KA. Nicotine discrimination in men and women. Pharmacol Biochem Behav 1999;64(2):295-9. http://dx.doi.org/10.1016/S0091-3057(99)00085-4
91. Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB. Gender differences in smoking cessation. J Consult Clin Psychol 1999;67(4):555-62. http://dx.doi.org/10.1037/0022-006X.67.4.555
92. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 2006;79(5):480-8. http://dx.doi.org/10.1016/j.clpt.2006.01.008
93. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46. http://dx.doi.org/10.1183/09031936.04.00014304
94. Lima JJ, Mohamed MH, Self TH, Eberle JV, Johnson JA. Importance of beta(2)adrenergic receptor genotype, gender and race on albuterol-evoked bronchodilation in asthmatics. Pulm Pharmacol Ther 2000;13(3):127-34. http://dx.doi.org/10.1006/pupt.2000.0239
95. Tashkin D, Celli B, Kesten S, Lystig T, Decramer M. Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial. Respir Med 2010;104(10):1495-504. http://dx.doi.org/10.1016/j.rmed.2010.03.033
96. Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P; TRISTAN Study Group. Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Respir Med 2004;98(11):1045-50. http://dx.doi.org/10.1016/j.rmed.2004.03.017
97. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356(8):775-89. http://dx.doi.org/10.1056/NEJMoa063070
98. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008;178(4):332-8. http://dx.doi.org/10.1164/rccm.200712-1869OC
99. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359(15):1543-54. http://dx.doi.org/10.1056/NEJMoa0805800
100. Tashkin DP, Rennard SI, Martin P, et al. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Drugs 2008;68(14):1975-2000. http://dx.doi.org/10.2165/00003495-200868140-00004
101. Rennard SI, Tashkin DP, McElhattan J, et al. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: a results from a 1-year randomized controlled clinical trial. Drugs 2009;69(5):549-65. http://dx.doi.org/10.2165/00003495-200969050-00004
102. Lizak MK, Nash E, Zakliczynski M, Sliwka J, Knapik Pm, Zembala M. Additional spirometry criteria predict postoeperative complications after coronary after bypass grafting (CABG) independently of concomitant chronic obstructive pulmonary disease: when is off-pump CABG more beneficial? Pol Arch Med Wewn 2009;119(9):550-7.
103. Haave E, Skumlien S, Hyland ME. Gender considerations in pulmonary rehabilitation. J Cardiopulm Rehabil Prev 2008;28(3):215-19.
104. Foy CG, Rejeski WJ, Berry MJ, Zacarro D, Woodard CM. Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest 2001;119(1):70-6. http://dx.doi.org/10.1378/chest.119.1.70
105. Franklin KA, Gustafson T, Ranstam J, Strom K. Survival and future need of longterm oxygen therapy for chronic obstructive pulmonary disease-gender differences. Respir Med 2007;101(7):1506-11. http://dx.doi.org/10.1016/j.rmed.2007.01.009
106. Machado MC, Krishnan JA, Buist SA, et al. Sex differences in survival of oxygendependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174(5):524-9. http://dx.doi.org/10.1164/rccm.200507-1057OC
107. Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease-United States, 2000-2005. Morb Mortal Wkly Rep 2008;57(45):1229-32.
108. Cote CG, Pinto-Plata VM, Marin JM, Nekach H, Dordelly LJ, Celli BR. The modified BODE index: validation with mortality in COPD. Eur Respir J 2008;32(5):1269-74. http://dx.doi.org/10.1183/09031936.00138507
109. Lange P, Nyboe, Appleyard M, Jensen G, Schnor. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990;45(8):579-85. http://dx.doi.org/10.1136/thx.45.8.579
110. Nilsson S, Carstensen JM, Pershagen G. Mortality among male and female smokers in Sweden: a 33 year follow up. J Epidemiol Community Health 2001;55(11):825-30. http://dx.doi.org/10.1136/jech.55.11.825